Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 170Neoplasm Metastasis 139Neoplasms 136Leukemia, Myeloid, Acute 133Colorectal Neoplasms 115Breast Neoplasms 115Melanoma 90Ovarian Neoplasms 88Prostatic Neoplasms 85Recurrence 83Multiple Myeloma 81Lung Neoplasms 73Squamous Cell Carcinoma of Head and Neck 72Glioblastoma 71Pancreatic Neoplasms 70Myelodysplastic Syndromes 63Lymphoma, Non-Hodgkin 59Triple Negative Breast Neoplasms 53Glioma 53Stomach Neoplasms 49Endometrial Neoplasms 46Brain Neoplasms 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma, Large B-Cell, Diffuse 45Carcinoma, Renal Cell 45Small Cell Lung Carcinoma 44Lymphoma, Follicular 40Lymphoma, B-Cell 40Carcinoma, Hepatocellular 40Sarcoma 39

Interventions

alkaloid GB18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Cachexia × 90 days × Clear all
NCT07338487 2026-04-24

A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Second Xiangya Hospital of Central South University

Phase 1 Recruiting
88 enrolled

Cachexia

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

Kexing Biopharm Co., Ltd.

Phase 1 Not yet recruiting
18 enrolled

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡